口服避孕药的配方和社会认知性能:一个简短的沟通
Minhal Mussawar1, Sneha Chenji1, Christine Bueno1
1Department of Psychology, University of Regina, Regina, SK, Canada.
Therapeutic advances in psychopharmacology
|November 5, 2025
概括
有抗雄激素孕激素的口服避孕药 (OCs) 可能会增加感知到的情绪强度和拒绝敏感性. 然而,这些影响并没有影响用户的整体情绪或认知功能.
科学领域:
- 神经科学是一个神经科学.
- 心理学 心理学 心理学
- 内分泌学 在内分泌学.
背景情况:
- 口服避孕药 (OCs) 在乙雌激醇 (EE) 剂量和孕激素类型上有所不同,可能会影响认知和情绪能力.
- EE剂量和孕激素的雄激素性对这些能力的具体影响仍然不清楚.
研究的目的:
- 研究不同口服避孕药配方对认知和情绪的影响.
- 为了比较低剂量和高剂量EE的效果,以及雄激素与抗雄激素孕激素的效果.
主要方法:
- 在线主体间实验设计,有96名参与者被分为四个OC组.
- 使用可重复电池评估神经心理状态的认知功能评估.
- 评估情绪处理和使用情绪识别任务的影响,积极和消极影响表,以及拒绝敏感度的措施.
主要成果:
- 使用抗雄激素OCs的参与者报告了情绪面孔的强度评级较高.
- 反雄激素OC使用者在社会压力因素 (Cyberball任务) 后表现出更高的不安全感.
- 在OC配方之间,在整体积极/消极影响或客观认知表现方面没有发现显著差异.
结论:
- 含有抗雄激素孕激素的OC配方与感知到的情绪强度和拒绝敏感度的增加有关.
- 尽管存在微妙的情绪处理差异,但OC配方并没有显著改变整体影响或认知表现.
相关概念视频
Birth Control Methods
5.8K
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
5.8K
Hormonal Control of the Ovarian Cycle
6.4K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
6.4K
Hormonal Regulation of the Menstrual Cycle
1.4K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
1.4K
The Placebo Effect
6.8K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.8K
Infertility in Females
3.6K
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
3.6K
Dosage Regimens: Designs and Approaches
250
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
250


